On recordAs of Nov 9, 2026
ChampionX no longer trades under CHX.
The filings below run to Aug 13, 2025.

Congress trades
No longer trading under CHX.
16 Congress trades · last filed Aug 13, 2025
On recordAs of Nov 9, 2026
ChampionX no longer trades under CHX.
The filings below run to Aug 13, 2025.
EarningsQ1 FY2025 · reported Apr 29, 2025
Q1 FY2025: Beat on EPS. Revenue missed by 2.8%.
EPS Q1 FY2025
Revenue Q1 FY2025
Beat 3 · In line 1 · Miss 2
CongressSTOCK Act disclosures to the House and Senate
16 Congress disclosures shown, from 6 members.
| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q1 FY2025reported Apr 29, 2025 | $0.50 | $0.40 | $864.5M | $889.0M | EPS beatRevenue miss |
| Q4 FY2024reported Feb 4, 2025 | $0.50 | $0.47 | $912.0M | $942.1M | EPS beatRevenue miss |
| Q3 FY2024reported Oct 23, 2024 | $0.44 | $0.46 | $906.5M | $945.1M | EPS missRevenue miss |
| Q2 FY2024reported Jul 24, 2024 | $0.37 | $0.45 | $893.3M | $959.3M | EPS missRevenue miss |
| Q1 FY2024reported Apr 24, 2024 | $0.50 | $0.40 | $922.1M | $921.6M | EPS beatRevenue in line |
| Q4 FY2023reported Feb 5, 2024 | $0.44 | $0.44 | $943.6M | $948.0M | EPS in lineRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Mr. SomasundaramPresident and Chief Executive Officer | $954K | $5.5M | $1.4M | $7.8M |
| Mr. FisherExecutive Vice President and Chief Financial Officer | $652K | $1.7M | $681K | $3.0M |
| Mr. BryantChief Operating Officer and President, Chemical Technologies | $655K | $1.3M | $573K | $2.5M |
| Mr. MahoneyPresident, Production & Automation Technologies | $512K | $888K | $477K | $1.9M |
| Ms. WrightSenior Vice President, General Counsel and Secretary | $485K | $888K | $432K | $1.8M |
The summary compensation table from the proxy statement for fiscal 2024, with titles as filed then. Executives who have since left are not shown. Read the filing
Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jul 16, 2025 | Jun 11, 2025 | Aug 13, 2025 | 63d | |
| Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Jul 16, 2025 | Jun 24, 2025 | Aug 13, 2025 | 50d | |
| Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Jul 16, 2025 | Apr 7, 2025 | May 14, 2025 | 37d | |
| Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Jul 16, 2025 | Apr 9, 2025 | May 6, 2025 | 27d | |
| Stock | Sale | $15,001 - $50,000 | n/aPrice history ends Jul 16, 2025 | Nov 16, 2023 | Dec 4, 2023 | 18d | |
| Stock | Purchase | $15,001 - $50,000 | n/aPrice history ends Jul 16, 2025 | Sep 19, 2023 | Nov 1, 2023 | 43d | |
| Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Jul 16, 2025 | Jun 29, 2023 | Aug 13, 2023 | 45d | |
| Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jul 16, 2025 | Apr 10, 2023 | May 19, 2023 | 39d | |
| Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jul 16, 2025 | Apr 5, 2023 | May 19, 2023 | 44d | |
| Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jul 16, 2025 | Mar 1, 2023 | Apr 17, 2023 | 47d | |
| Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Jul 16, 2025 | Nov 30, 2022 | Dec 29, 2022 | 29d | |
| Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jul 16, 2025 | Apr 21, 2022 | May 16, 2022 | 25d | |
| Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jul 16, 2025 | Jan 5, 2021 | Feb 10, 2021 | 36d | |
| Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jul 16, 2025 | Jan 7, 2021 | Feb 10, 2021 | 34d | |
| Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jul 16, 2025 | Jan 12, 2021 | Feb 10, 2021 | 29d | |
| Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jul 16, 2025 | Jan 13, 2021 | Feb 10, 2021 | 28d |
We hold no closing prices for any row shown here, so no move is shown. Not investment advice.
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Every Congress trade in CHX filterable by party, chamber, type and account.
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.
Data as of Nov 9, 2026.
What the filings on CHX show and how current they are.
Lisa C. McClain, Josh Gottheimer, Gilbert Ray Cisneros, Jr., Jonathan L. Jackson, Daniel S. Goldman and Susie Lee disclosed CHX transactions in the filings shown here.
Congressional disclosures took a median of 37 days, against the 45 the STOCK Act allows.